Sun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc.
- Sun Pharma secured exclusive rights to commercialize and manufacture Lerodalcibep worldwide, excluding the US and China
- The licensing deal gives Sun Pharma a potential global product opportunity outside the US and China
